Although the status of EGFR was not analyzed, the effect of BMP4 on glioma cells was mediated by its downstream targets, p21CIP1 and ID1 (DNA-binding protein inhibitor 1). The gene discussed is CDKN1A; the disease is central nervous system cancer.